Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma

doi:10.3748/wjg.v20.i46.17483

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 46

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7113)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

476

WORD

350

HTML

3604

Figures (1-2)

253

Tables (1-3)

194

Sum=4877

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1084

Download

1152

Sum=2236

Dec 14, 2014 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Dec 14, 2014; 20(46): 17483-17490
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17483

Table 3 Cox proportion hazards regression multivariate analysis results

Variable	B	SE	Sig	Exp(B)	Wald	95%CI for Exp(B)
Variable	B	SE	Sig	Exp(B)	Wald	Lower	Upper
Tumor size	1.038	0.288	0	2.824	13.039	1.608	4.962
PVTT	1.464	0.378	0	4.324	15.011	2.062	9.068
BCLC stage	0.383	0.165	0.020	1.467	5.3830	1.016	2.028
ECOG score	0.564	0.282	0.045	1.757	4.0030	1.012	3.053
MWA	-0.602	0.157	0	0.547	14.689	0.402	0.745
TD	0.670	0.213	0.001	2.107	10.203	1.335	3.143

PVTT: Portal vein tumor thrombus; BCLC: Barcelona Clinic Liver Cancer; ECOG: Eastern Cooperative Oncology Group; MWA: Microwave ablation; TD: Targeted drugs.

Citation: Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma. World J Gastroenterol 2014; 20(46): 17483-17490
URL: https://www.wjgnet.com/1007-9327/full/v20/i46/17483.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i46.17483